Apixaban is a trusted anticoagulant used to reduce the risk of stroke and blood clots, particularly in patients with atrial fibrillation (AFib) or deep vein thrombosis (DVT). The 2.5 mg dose is often prescribed for long-term use in patients at a higher risk of bleeding or those with reduced kidney function. It's also commonly used for extended prevention following certain surgeries.

Meanwhile, the 5 mg dose is typically recommended for most adults as the standard starting point for clot prevention. Doctors may adjust the dosage based on age, weight, kidney health, and concurrent medications.

Both dosages work by blocking Factor Xa, a key enzyme in the blood clotting process, and are taken orally, twice daily.

Explore both Apixaban 2.5 mg and 5 mg on Capsule1 for clinically backed, doctor-trusted clot prevention.